KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Revisiting the Effect of Udenafil on Exercise Performance in Patients With Fontan Circulation: Results of a Post Hoc Analysis of the FUEL Trial.

David J Goldberg, Victor Zak, Chenwei Hu, Adam M Lubert, Rahul H Rathod, Daniel J Penny, Robert Whitehill, Kurt R Schumacher, Salil Ginde, Michelle Ploutz, Gi Beom Kim, Todd T Nowlen, Michael V DiMaria, Benjamin P Frischhertz, Jonathan B Wagner, Kimberly E McHugh, Brian W McCrindle, Mark J Cartoski, Jon Detterich, Anji T Yetman, Anitha S John, Marc E Richmond, Matthew Files, R Mark Payne, Andrew S Mackie, Christopher K Davis, William B Orr, Ruchira Garg, Kevin D Hill, Jennifer S Yauck, Michael G McBride, James Yeager, Gail D Pearson, Stephen M Paridon, Bryan H Goldstein

J Am Heart Assoc 14(16) e041348

PMID40792599
PMCIDPMC12533643
DOI10.1161/JAHA.125.041348
发表日期2025-08-12
入排依据:未发现恶性肿瘤人群证据。
已检查 4 张 PubMed Figure,均未识别为 KM 图:Figure 1:AI 判定为 other;Figure 2:AI 判定为 other;Figure 3:AI 判定为 other;Figure 4:AI 判定为 other。
摘要

摘要

BACKGROUND: In the FUEL (Fontan Udenafil Exercise Longitudinal) trial, a positive treatment effect was identified for outcomes at the ventilatory anaerobic threshold but not for the primary outcome, oxygen consumption (Vo2) at peak exercise. This disparate response may be explained by the physiologic challenge of improving peak Vo2 in participants with near-normal baseline exercise performance. METHODS: Participants were divided into subgroups by baseline predicted peak Vo2 (<80% versus ≥80%). Treatment effect was evaluated in those with a baseline peak Vo2 <80% predicted and linear regression was performed to examine the interaction between subgroup and response to therapy for the primary and secondary outcomes. RESULTS: Of the 379 participants with paired exercise data, 302 (80%) had a baseline peak Vo2 <80% predicted. In this subgroup, the primary outcome of peak Vo2 improved significantly after 6 months of udenafil treatment, when compared with placebo (0.23±4.17 mL/kg per min versus -0.90±3.74 mL/kg per min; P=0.021). Secondary outcome measures, including Vo2 at ventilatory anaerobic threshold (P=0.023), work at ventilatory anaerobic threshold (P=0.032), and the myocardial performance index (P=0.007) were all significantly improved as well. A significant interaction was found between exercise subgroups and response to udenafil for peak Vo2 (P=0.036) but not for other outcomes. CONCLUSIONS: In this post hoc subgroup analysis, after exclusion of patients with Fontan circulation with near-normal baseline peak Vo2, a positive treatment effect of udenafil was identified for the primary outcome of peak Vo2. The interaction between baseline peak Vo2 and treatment may have influenced the outcome of the FUEL trial. REGISTRATION: URL: https://clinicaltrials.gov; Unique identifier: NCT0274115.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(4,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1Figure 1. Box and whisker plot demonstrating a comparison of change in peak V o 2 between participants treated with placebo and those treated with udenafil for participants with baseline peak V o 2 ≤80% predicted. V o 2 indicates oxygen consumption.
非 KM Figure
Figure 2Figure 2. Box and whisker plot demonstrating a comparison of change in V o 2 at the ventilatory anaerobic threshold between participants treated with placebo and those treated with udenafil for participants with baseline peak V o 2 ≤80% predicted. V o 2 indicates oxygen consumption.
非 KM Figure
Figure 3Figure 3. Box and whisker plot demonstrating a comparison of change in work at the VAT between participants treated with placebo and those treated with udenafil for participants with baseline peak V o 2 ≤80% predicted. VAT indicates ventilatory anaerobic threshold; V o 2 , oxygen consumption.
非 KM Figure
Figure 4Figure 4. Box and whisker plot demonstrating a comparison of change in ventilatory equivalents of carbon dioxide at the ventilatory anaerobic threshold between participants treated with placebo and those treated with udenafil for participants with baseline peak V o 2 ≤80% predicted. VE/VCO 2 indicates ratio of minute ventilation to minute carbon dioxide production V o 2 oxygen consumption.
非 KM Figure